BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Treatment
91 results:

  • 1. Oncocytoid Salivary Tumors: Differential Diagnosis and Utility of Newly Described Immunohistochemistry.
    Katabi N
    Head Neck Pathol; 2024 Mar; 18(1):20. PubMed ID: 38502259
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Whole-Genome Sequencing Analysis of Male breast cancer Unveils Novel Structural Events and Potential Therapeutic Targets.
    Al Assaad M; Michaud O; Semaan A; Sigouros M; Tranquille M; Phan A; Levine MF; Gundem G; Medina-Martínez JS; Papaemmanuil E; Manohar J; Wilkes D; Sboner A; Hoda SAF; Elemento O; Mosquera JM
    Mod Pathol; 2024 Apr; 37(4):100452. PubMed ID: 38369186
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients.
    Zheng X; Fang M; Fan Y; Sun Y; Sun M; Yang A; Zhang B; Liu Q; Liu H; Zhou X; Huang T; Qin J; Wang Z; Qin M; Shen Z; Yao S; Yang J; Wang Y; Gao M
    Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38261313
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
    Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Ntrk fusions in solid tumours: what every pathologist needs to know.
    Nguyen MA; Colebatch AJ; Van Beek D; Tierney G; Gupta R; Cooper WA
    Pathology; 2023 Aug; 55(5):596-609. PubMed ID: 37330338
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Ntrk gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS.
    Zito Marino F; Buono S; Montella M; Giannatiempo R; Messina F; Casaretta G; Arpino G; Vita G; Fiorentino F; Insabato L; Sgambato A; Orditura M; Franco R; Accardo M
    J Pathol Clin Res; 2023 Sep; 9(5):367-377. PubMed ID: 37143440
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Tumor Microenvironment in Male breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression.
    Brcic I; Kluba AM; Godschachner TM; Suppan C; Regitnig P; Dandachi N; Lax SF; Balić M
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614261
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Precision oncology using organoids of a secretory carcinoma of the salivary gland treated with trk-inhibitors.
    Lassche G; van Engen-van Grunsven ACH; van Hooij O; Aalders TW; Am Weijers J; Cocco E; Drilon A; Hoischen A; Neveling K; Schalken JA; Verhaegh GW; van Herpen CML
    Oral Oncol; 2023 Feb; 137():106297. PubMed ID: 36610231
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Risk factors of recurrence or metastasis in patients with medullary thyroid carcinoma].
    Guo FL; Li LJ; Ruan XH; Fu GM; Zhao JZ; Hou XK; Gao M; Zheng XQ
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3849-3855. PubMed ID: 36540922
    [No Abstract]    [Full Text] [Related]  

  • 10. Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma.
    Yue W; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():1025629. PubMed ID: 36506082
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Expression and Signaling Pathways of Nerve Growth Factor (NGF) and Pro-NGF in breast cancer: A Systematic Review.
    Bruno F; Arcuri D; Vozzo F; Malvaso A; Montesanto A; Maletta R
    Curr Oncol; 2022 Oct; 29(11):8103-8120. PubMed ID: 36354700
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Ntrk Gene Fusions and treatment in Ntrk Fusion-Positive Solid cancers].
    Fukuda M; Naito Y
    Gan To Kagaku Ryoho; 2022 Oct; 49(10):1048-1050. PubMed ID: 36281593
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expert consensus on the diagnosis and treatment of Ntrk gene fusion solid tumors in China.
    Xu C; Si L; Wang W; Li Z; Song Z; Wang Q; Liu A; Yu J; Fang W; Zhong W; Wang Z; Zhang Y; Liu J; Zhang S; Cai X; Liu A; Li W; Zhan P; Liu H; Lv T; Miao L; Min L; Chen Y; Yuan J; Wang F; Jiang Z; Lin G; Pu X; Lin R; Liu W; Rao C; Lv D; Yu Z; Lei L; Li X; Tang C; Zhou C; Zhang J; Xue J; Guo H; Chu Q; Meng R; Wu J; Zhang R; Hu X; Zhou J; Zhu Z; Li Y; Qiu H; Xia F; Lu Y; Chen X; Ge R; Dai E; Han Y; Pan W; Luo J; Jia H; Dong X; Pang F; Wang K; Wang L; Zhu Y; Xie Y; Lin X; Cai J; Wei J; Lan F; Feng H; Wang L; Du Y; Yao W; Shi X; Niu X; Yuan D; Yao Y; Huang J; Zhang Y; Sun P; Wang H; Ye M; Wang D; Wang Z; Wan B; Lv D; Wei Q; Kang J; Zhang J; Zhang C; Yu G; Ou J; Shi L; Li Z; Liu Z; Liu J; Yang N; Wu L; Wang H; Jin G; Yang L; Wang G; Fang M; Fang Y; Li Y; Wang X; Zhang Y; Ma S; Wang B; Zhang X; Song Y; Lu Y
    Thorac Cancer; 2022 Nov; 13(21):3084-3097. PubMed ID: 36127731
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Biomarkers for Systemic Therapy in Metastatic breast cancer: ASCO Guideline Update.
    Henry NL; Somerfield MR; Dayao Z; Elias A; Kalinsky K; McShane LM; Moy B; Park BH; Shanahan KM; Sharma P; Shatsky R; Stringer-Reasor E; Telli M; Turner NC; DeMichele A
    J Clin Oncol; 2022 Sep; 40(27):3205-3221. PubMed ID: 35759724
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. trk Inhibition with Entrectinib in Metastatic Salivary Secretory Carcinoma (SC): A Case Report.
    Ernst MS; Lysack JT; Hyrcza MD; Chandarana SP; Hao D
    Curr Oncol; 2022 May; 29(6):3933-3939. PubMed ID: 35735423
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The promise of trk inhibitors in pediatric cancers with Ntrk fusions.
    Blauel ER; Laetsch TW
    Cancer Genet; 2022 Apr; 262-263():71-79. PubMed ID: 35108663
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Multifunctional Nanoparticles Loaded with Vascular Endothelial Growth Factor Inhibitors and MED1 siRNA to Inhibit breast cancer Progression by Targeting Tumor-Associated Macrophages and breast cancer Cells.
    Wang S; Luo Z; Zhou X; Wang C; Luo Y; Yi N; Liao YL
    J Biomed Nanotechnol; 2021 Dec; 17(12):2364-2373. PubMed ID: 34974859
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pure and Mixed Tubular Carcinoma of the breast: Mammographic Features, Clinicopathological Characteristics and Prognostic Analysis.
    Wen C; Xu W; Qin G; Zeng H; He Z; Wang S; Xu Z; Ma M; Luo Z; Chen W
    Technol Cancer Res Treat; 2021; 20():15330338211045198. PubMed ID: 34918991
    [No Abstract]    [Full Text] [Related]  

  • 19. Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review.
    Lian J; Wang LX; Guo JH; Bu P; Xi YF; Yun KM
    Diagn Pathol; 2021 Oct; 16(1):89. PubMed ID: 34629079
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Is patient participation in multidisciplinary tumour conferences associated with their information needs? A multicentre prospective observational study.
    Reck S; Diekmann A; Heuser C; Schellenberger B; Ansmann L; Wirtz MA; Ernstmann N
    BMJ Open; 2021 Sep; 11(9):e049199. PubMed ID: 34556513
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.